Pfizer shares fall as 2026 profit view comes in below expectations

Shares of drugmaker Pfizer PFE.N fall 3.3% to $25.95

Co forecasts 2026 adj. profit of $2.80-$3.00 per share, below analysts' average estimate of $3.05 - LSEG data

Says it expects a drop in sales of its COVID products and a revenue hit from the loss of exclusivity on some older drugs

Expects 2026 revenue of $59.50 billion to $62.50 billion, the midpoint of which is lower than analysts' estimates of $61.59 billion

Including session's moves, stock down 2% YTD